ASSOCIATIONS BETWEEN MOLECULAR SUBTYPES AND POSTOPERATIVE COMPLICATIONS AFTER PRIMARY CYTOREDUCTIVE SURGERY FOR ADVANCED STAGE HIGH-GRADE SEROUS OVARIAN CANCER

被引：0
|
作者：
Torres, D. [1 ]
Kumar, A. [1 ]
Bakkum-Gamez, J. [1 ]
Langstraat, C. [1 ]
Goode, E. [2 ]
Cliby, W. [1 ]
Wang, C. [2 ]
机构：
[1] Mayo Clin, Gynecol Surg, Rochester, MN USA
[2] Mayo Clin, Hlth Sci Res, Rochester, MN USA
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2017年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO7-0806
引用
收藏
页码：1693 / 1693
页数：1
相关论文
共 50 条
  • [21] Comparison of tumor progression model secretome to molecular subtypes of high-grade serous ovarian cancer
    Lanfredi, Guilherme Pauperio
    Teibo, John Oluwafemi
    Grassi, Mariana Lopes
    Masson, Ana Paula
    Faca, Vitor Marcel
    BIOPHYSICAL REVIEWS, 2021, 13 (06) : 1434 - 1435
  • [22] PREDICTORS OF POSTOPERATIVE MORBIDITY AFTER CYTOREDUCTIVE SURGERY FOR ADVANCED OVARIAN CANCER: ANALYSIS AND MANAGEMENT OF COMPLICATIONS
    Di Donato, V.
    Di Pinto, A.
    Benedetti, E.
    Palaia, I.
    Perniola, G.
    Schiavi, M.
    Musella, A.
    Tomao, F.
    Muzii, L.
    Panici, P. Benedetti
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A35 - A36
  • [23] Nomogram prediction model of severe postoperative complications after cytoreductive surgery for advanced ovarian cancer
    Cao, Gai Jing
    Wang, Xingguo
    Xu, Zhiyang
    Li, Ziyi
    Liu, Shujuan
    Fu, Yue
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A136 - A137
  • [24] Survival impact of complete cytoreductive surgery in the primary management of FIGO stage IIIC, high-grade, epithelial ovarian cancer
    Santillan, A.
    Tanner, E., III
    Guile, M.
    Mulla, Z.
    Diaz-Montes, T. P.
    Giuntoli, R. L., II
    Bristow, R. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [25] Toxicity and Therapy Outcome Associations in High-grade Serous Ovarian Cancer
    Deng, F.
    Laasik, M.
    Salminen, L.
    Lapatto, L.
    Huhtinen, K.
    Li, Y.
    Hautaniemi, S.
    Hynninen, J.
    Niemi, M.
    Lehtonen, R.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S96 - S96
  • [26] PREDICTIVE FACTORS OF POSTOPERATIVE COMPLICATIONS AFTER CYTOREDUCTIVE SURGERY FOR OVARIAN CANCER
    Atallah, D.
    Sarkis, Y.
    Richa, F.
    Sleilaty, G.
    Moubarak, M.
    El Kassis, N.
    Chahine, G.
    Chalhoub, V.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A500 - A500
  • [27] Predictive factors of postoperative complications after cytoreductive surgery for ovarian cancer
    Atallah, D.
    Moubarak, M.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 149 - 150
  • [28] Defining the Molecular Footsteps of High-Grade Serous Ovarian Cancer
    Nagendra, P.
    Lombard, J.
    Jamaluddin, F.
    Tanwar, P.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 26 - 26
  • [29] PREDICTIVE FACTORS OF POSTOPERATIVE COMPLICATIONS AFTER CYTOREDUCTIVE SURGERY FOR OVARIAN CANCER
    Atallah, D.
    Sarkis, Y.
    Richa, F.
    Sleilaty, G.
    Moubarak, M.
    El Kassis, N.
    Chahine, G.
    Chalhoub, V.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A117 - A118
  • [30] Urinary concentrations of phthalate metabolites and the survival of high-grade serous ovarian cancer with advanced stage
    Zheng, Wen-Rui
    Li, Yi-Zi
    Xu, Jin
    Liu, Ke-Xin
    Liu, Fang-Hua
    Xing, Wei-Yi
    Liu, Jia-Xin
    Wu, Lang
    Li, Xiao-Ying
    Huang, Dong-Hui
    Gong, Ting-Ting
    Wu, Qi-Jun
    ENVIRONMENTAL POLLUTION, 2025, 370
12345